News by Subject Biology

UC San Diego study supports launch of Phase I clinical trial to test a designer DNA agent -- an antisense oligonucleotide that targets a gene called IRF4 -- in patients with multiple myeloma.

Dr. Claude Brodski, M.D., head of the BGU's Laboratory for Molecular Neuroscience, discovered that BMP5/7 signaling in neurons was significantly reduced in dopamine-producing brain cells, which could contribute to Parkinson's disease advancement.

Gene editing therapies, including CRISPR-Cas systems, offer the potential to correct mutations causing inherited retinal degenerations, a leading cause of blindness. Technological advances in gene editing, continuing safety concerns, and strategies to overcome these challenges

Researchers captured and comparted hi-res images of ribosome structures from sensitive and resistant bacteria and report that a water molecule needed for antibiotic binding was not present in the ribosomes from the drug-resistant bugs.

Study finds NAD+ break down leads to multi organ scarring, providing now a previously undiscovered pathogenic role of the enzyme CD38 in disease scarring.

Histamine is a dangerous compound that occurs in spoiled food, such as mackerel, left at room temperature for too long. Unfortunately, existing histamine detection methods are inconvenient and expensive. To tackle this issue, a team of scientists from Chung-Ang University, Korea, has developed a novel histamine quantification strategy based on fluorescent carbon nanoparticles and histamine-binding peptides. Their approach is simple and inexpensive and allows one to efficiently assess food safety.